NO822801L - Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner

Info

Publication number
NO822801L
NO822801L NO822801A NO822801A NO822801L NO 822801 L NO822801 L NO 822801L NO 822801 A NO822801 A NO 822801A NO 822801 A NO822801 A NO 822801A NO 822801 L NO822801 L NO 822801L
Authority
NO
Norway
Prior art keywords
furants
disubstituted
procedure
preparation
therapeutic active
Prior art date
Application number
NO822801A
Other languages
English (en)
Other versions
NO159448C (no
NO159448B (no
Inventor
Leonardo De Vincentiis
Original Assignee
Ausonia Farma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11208027&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO822801(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ausonia Farma Srl filed Critical Ausonia Farma Srl
Publication of NO822801L publication Critical patent/NO822801L/no
Publication of NO159448B publication Critical patent/NO159448B/no
Publication of NO159448C publication Critical patent/NO159448C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO822801A 1981-08-18 1982-08-17 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin. NO159448C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23546/81A IT1168163B (it) 1981-08-18 1981-08-18 Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative

Publications (3)

Publication Number Publication Date
NO822801L true NO822801L (no) 1983-02-21
NO159448B NO159448B (no) 1988-09-19
NO159448C NO159448C (no) 1988-12-28

Family

ID=11208027

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822801A NO159448C (no) 1981-08-18 1982-08-17 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin.

Country Status (23)

Country Link
US (1) US4431664A (no)
JP (1) JPS5859982A (no)
KR (1) KR860000851B1 (no)
AR (1) AR230444A1 (no)
AT (1) AT383597B (no)
AU (1) AU533719B2 (no)
BE (1) BE894093A (no)
CA (1) CA1182121A (no)
CH (1) CH650259A5 (no)
DE (1) DE3230265C2 (no)
DK (1) DK156067C (no)
ES (1) ES515068A0 (no)
FR (1) FR2511675A1 (no)
GB (1) GB2104071B (no)
GR (1) GR76260B (no)
IT (1) IT1168163B (no)
LU (1) LU84340A1 (no)
NL (1) NL186447C (no)
NO (1) NO159448C (no)
PH (1) PH19228A (no)
PT (1) PT75440B (no)
SE (1) SE448456B (no)
ZA (1) ZA825718B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1175808B (it) * 1984-03-07 1987-07-15 Ausonia Farma Srl Procedimento per la preparazione di composto con attivita' antiulcera
IT1196133B (it) * 1984-06-06 1988-11-10 Ausonia Farma Srl Derivati furanici con attivita' antiulcera
KR950009825B1 (ko) * 1986-03-28 1995-08-29 자누스 화마스티씨 에스.알.엘. 치료학적 항궤양 활성이 있는 니페로티딘의 합성방법
HU9203905D0 (en) * 1989-04-05 1993-04-28 Glaxo Group Ltd Method for producing ranitidine
JPH0416036U (no) * 1990-05-31 1992-02-10

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140681A (en) * 1974-11-08 1979-02-20 Mitsubishi Chemical Industries, Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
SE8204670D0 (sv) 1982-08-12
JPS5859982A (ja) 1983-04-09
PT75440B (en) 1986-02-04
DE3230265A1 (de) 1983-03-03
FR2511675B1 (no) 1984-02-10
LU84340A1 (fr) 1983-02-28
DK357182A (da) 1983-02-19
KR840001162A (ko) 1984-03-28
GB2104071B (en) 1985-03-27
DK156067B (da) 1989-06-19
KR860000851B1 (ko) 1986-07-09
JPS6335631B2 (no) 1988-07-15
CA1182121A (en) 1985-02-05
ZA825718B (en) 1983-06-29
NL186447C (nl) 1990-12-03
FR2511675A1 (fr) 1983-02-25
NL186447B (nl) 1990-07-02
NO159448C (no) 1988-12-28
IT1168163B (it) 1987-05-20
NL8203160A (nl) 1983-03-16
ES8306372A1 (es) 1983-06-01
AU8673182A (en) 1983-02-24
AU533719B2 (en) 1983-12-08
GR76260B (no) 1984-08-04
BE894093A (nl) 1982-12-01
GB2104071A (en) 1983-03-02
AT383597B (de) 1987-07-27
AR230444A1 (es) 1984-04-30
US4431664A (en) 1984-02-14
CH650259A5 (it) 1985-07-15
DK156067C (da) 1989-12-04
SE448456B (sv) 1987-02-23
SE8204670L (sv) 1983-02-19
PT75440A (en) 1982-09-01
ES515068A0 (es) 1983-06-01
NO159448B (no) 1988-09-19
ATA312282A (de) 1986-12-15
DE3230265C2 (de) 1984-09-20
IT8123546A0 (it) 1981-08-18
PH19228A (en) 1986-02-12

Similar Documents

Publication Publication Date Title
NO156940C (no) AnlogifremgangsmŸte til fremstilling av terapeutisk aktive cis, endo-2-azabicyklo-(3.3.0)-oktan-3-karboksylsyrer.
NO154905C (no) Fremgangsmaate for fremstilling av preparater for behandling av melanomer.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO158419C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO814424L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO165104C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.
NO822801L (no) Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner
NO157421C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3,7-diazabicyclo-(3.3.1)-nonan-derivater.